Using these specialized PVDF processing aids also increases line speed to boost production efficiency and lower total energy consumption.

According to the United Nations, one-third of food intended for human consumption is wasted annually.

Device protection

Device protection

Optimally designed medical wearable devices can better aid patients and physicians as they seek tools and strategies to promote better health outcomes.    

Device protection

With a dielectric constant (Dk) range spanning 2.55 to 23, these materials are optimized to boost antenna efficiency and deliver lightweight solutions for 5G infrastructure and devices. Advanced technologies to help customers produce 3D Molded Interconnect Devices (MID) for antenna products. Telecom applications including antennas, mobile base stations and satellites, automotive and industrial radars and radomes, health and security technology such as body scanning and imaging devices.

120,000 BOARD MEMBER, MANAGING DIRECTOR 660613-3954 Nilsson, Bo Patrik Joakim, Hovslagaregatan 13, 271 57 YSTAD BOARD MEMBER, CHAIR OF THE BOARD 640503 Merklein, Norbert, Fichtenstrasse 20, 61476 KRONBERG IM TAUNUS, TYSKLAND BOARD MEMBERS 750618-4089 Norén, Jenny Eva Kristina, Fårabäcksvägen 68, 212 91 MALMÖ 610322 Smeds, Jan-Håkan, Chämiweg 23, NEFTENBACH, TYSKLAND AUDITORS 556029-6740 Öhrlings PricewaterhouseCoopers AB, Box 4009, 203 11 MALMÖ Represented by: 710921-4689 PRINCIPALLY RESPONSIBLE AUDITOR 710921-4689 Olsson, Karin Maria, c/o PwC, 405 32 GÖTEBORG SIGNATORY POWER e-Certificate of registration Swedish Companies Registration Office LIMITED COMPANY D1a- 6064988 Registration number Date of registration of the company Document created on Date of registration of current name Page 556393-1020 1990-04-10 2020-11-30 14:53 2020-11-30 2 (2) The board of directors is entitled to sign. Signatory power by any two jointly of the board members Furthermore, the Managing Director, in the course of normal business activities, is also entitled to sign.

PowerPoint Presentation MEDICAL DEVICE MANUFACTURER O S T O M Y B A G S E A L S • Comply with ISO 10993 and FDA Class II medical device regulations • Offer Good sealing performance • Provide technical supports for processing recommendations • Deliver a high compression set materials to improve comfort • Provided a medical-grade TPE to help the customer meet necessary regulatory specifications and gain market share • Provided technical support during design and the manufacturing process for EVA bonding • Delivered soft-touch feel and excellent sealing performance Versaflex HC Thermoplastic Elastomers - G2705 Formulation KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/thermoplastic-elastomers/versaflex-hc-thermoplastic-elastomers Slide 1: MEDICAL Device manufacturer

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; including recessionary conditions • The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • An inability to raise or sustain prices for products or services; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; • The ability to obtain required regulatory approvals and otherwise consummate the proposed sales of the Distribution business; and • Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions Use of Non-GAAP Measures This presentation includes the use of both GAAP (generally accepted accounting principles) and non-GAAP financial measures. Avient does not provide reconciliations of forward-looking non-GAAP financial measures, such as outlook for Adjusted EBITDA, Adjusted Earnings Per Share, Adjusted Operating Income and Free Cash Flow, to the most comparable GAAP financial measures on a forward-looking basis because Avient is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort.